Skip to main content

Table 2 Differentially expressed urine proteins

From: Plasma and urine biomarkers in acute viral hepatitis E

Identifier

Protein Name

Accession Number

Fold Change Expt 1(HEV Cy5; CON Cy3)

Fold Change Expt 2 (HEV Cy3; CON Cy5)

U1

Prostaglandin D2 synthase

21 kDa (Brain)

Q5SQ09

+2.16

-1.43

U2

- Zinc alpha 2 glycoprotein chain A

- Alpha 1 type I collagen, preprotein

1ZAGA

Q8N473_HUM

+4.97

-3.14

U3

Zinc alpha 2 glycoprotein chain A

1ZAGA

+6.58

-3.74

U4

Zinc alpha 2 glycoprotein chain A

1ZAGA

+6.98

-2.94

U5

KIAA0216 splice variant 1

Q5W9G1_HUM

+4.40

-1.85

U6

- Membrane associated guanylate kinase 2

- ODF2 protein

AAC05370

Q5BJF6_HUM

+3.33

-1.75

U7

FLJ00133 fragment

Q8TERO_HUM

+9.08

-1.83

U8

Serum albumin

AAA64922

-4.06

+8.67

U9

Serum albumin

AAA64922

-2.52

+6.67

U10

N2B-Titin Isoform

RasGAP-activating-like protein 1 variant

CAD12455

+9.42

-3.81

U11

Alpha-1 microglobulin/inter alpha trypsin inhibitor precursor

HCHU

+6.01

-3.63

U12

Alpha-1 microglobulin/inter alpha trypsin inhibitor precursor

HCHU

+7.59

-4.21

U13

Alpha-1 microglobulin/inter alpha trypsin inhibitor precursor

HCHU

+6.22

-2.81

  1. The differentially expressed urine proteins from Figure 3 were analysed by DeCyder 2D v6.5 and identified by mass spectrometry. The table shows the spot intensity fold-changes in hepatitis E patients (HEV) compared to healthy controls (CON). A dye swap experiment is also shown. The "+" and "-" values indicate increased or decreased expression, respectively, in patients compared to controls.